TCA
BIIB icon

Transcend Capital Advisors’s Biogen BIIB Stock Holding History

Transcend Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Buy
1,830
+181
+11% +$33.4K 0.03% 509
2025
Q4 		$290K Sell
1,649
-30
-2% -$4.9K 0.02% 527
2025
Q3 		$235K Buy
+1,679
New +$227K 0.02% 618
2024
Q1 		– Sell
-1,435
Closed -$371K – 536
2023
Q4 		$371K Hold
1,435
– – 0.03% 350
2023
Q3 		$369K Sell
1,435
-35
-2% -$9.36K 0.04% 342
2023
Q2 		$419K Sell
1,470
-118
-7% -$35.1K 0.04% 324
2023
Q1 		$442K Sell
1,588
-1,657
-51% -$458K 0.05% 302
2022
Q4 		$899K Sell
3,245
-600
-16% -$169K 0.1% 211
2022
Q3 		$1.03M Buy
3,845
+11
+0.3% +$2.34K 0.11% 193
2022
Q2 		$782K Buy
3,834
+1,809
+89% +$370K 0.08% 232
2022
Q1 		$426K Buy
2,025
+600
+42% +$130K 0.04% 342
2021
Q4 		$342K Buy
1,425
+38
+3% +$9.77K 0.03% 359
2021
Q3 		$376K Hold
1,387
– – 0.03% 336
2021
Q2 		$480K Buy
+1,387
New +$420K 0.07% 210
2020
Q4 		– Sell
-771
Closed -$219K – 378
2020
Q3 		$219K Buy
+771
New +$215K 0.04% 235

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Transcend Capital Advisors's BIIB Position: Q1 2026 in Review

Transcend Capital Advisors increased its Biogen (BIIB) stake by 11% in Q1 2026, buying an estimated $33.4K and bringing the position to 1,830 shares worth $335K. The position accounts for 0.03% of the portfolio, ranked #509.

Transcend Capital Advisors first reported a position in BIIB in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.03M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Transcend Capital Advisors held 1,830 shares of Biogen worth $335K as of Q1 2026.
  • Transcend Capital Advisors bought 181 Biogen shares in Q1 2026, an estimated $33.4K.
  • Biogen made up 0.03% of Transcend Capital Advisors's portfolio in Q1 2026, its #509 holding.
  • Transcend Capital Advisors first reported a position in Biogen in Q3 2020 and has held it in 15 quarters since.
  • Transcend Capital Advisors's Biogen position peaked at $1.03M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.